货号：UP827269269
| 产品信息 | |
| 产品名称： | NMDA |
| 中文名称： | N-甲基-D-天冬氨酸(请以英文为准,中文仅做参考) |
| CAS号： | 6384-92-5 |
| 分子式： | C5H9NO4 |
| 分子量： | 147.13 |
| MDL NO： | MFCD00004226 |
| 标准纯度： | 98+% (UP827269269) |
| 沸点： | 258.2°C at 760 mmHg |
| 储存： | Sealed in dry,Room Temperature (UP827269269) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Derazantinib
UP2301213551234356-69-4
MPTP hydrochloride
UP19254764823007-85-4
Fmoc-Ser(tBu)-Wang resin 100-200 mesh, 1% DVB
UP1288877044N/A
1-Bromo-2,3-dichlorobenzene
UP25968472956961-77-4
L-Cysteine
UP91324436852-90-4
PD166866
UP480167279192705-79-6
Phloretin
UP70184879560-82-2
BAY 11-7085
UP512004021196309-76-9
Arcyriaflavin A
UP379268238118458-54-1
PF-03716556
UP679138231928774-43-0
Polystyrene Resin 100-200 mesh, 1% DVB
UP66655591789003-70-7
6-Iodo-1H-indazole
UP273633762261953-36-0
Lansoprazole sodium
UP708901436226904-00-3
Dofetilide
UP590692429115256-11-6
(2R,3R,4R,5R)-3-(((1H-Imidazol-1-yl)sulfonyl)oxy)-5-((benzoyloxy)methyl)tetrahydrofuran-2,4-diyl dibenzoate
UP74654690797614-42-1
(1R,2R)-Cyclohexane-1,2-diamine
UP75341046620439-47-8
Fruquintinib
UP1166839161194506-26-7
CP-547632
UP343260540252003-65-9
Milnacipran hydrochloride
UP491137978101152-94-7
XL147
UP329485628934526-89-3
(3-Chloroprop-1-yn-1-yl)benzene
UP3013977573355-31-5
BMS-833923
UP1467072001059734-66-5
GS-9620
UP6441749161228585-88-3
Purmorphamine
UP240400495483367-10-8
SAG
UP772693345912545-86-9
N,N'-Bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylic Diimide
UP404621138882953-57-9
YHO-13351 free base
UP120979682912288-64-3
Lck Inhibitor
UP582775499847950-09-8
Ingenol Mebutate
UP50993856175567-37-2
25,26-Dihydroxyvitamin D3
UP85127925529261-12-9
SSR128129E
UP319198593848318-25-2
1-Methyl-1H-indole
UP446165866603-76-9
Topiroxostat
UP268465768577778-58-6
4-Methyl-3-nitrobenzoic acid
UP57559377896-98-0
Cryptotanshinone
UP76081164635825-57-1
Methyl 3-(4-hydroxy-3-methoxyphenyl)acrylate
UP8001785402309-07-1
Acteoside
UP52651281961276-17-3
Polyinosinic acid-polycytidylic acid
UP62669787024939-03-5
Dapagliflozin propanediol hydrate
UP339513932960404-48-2
XMU-MP-1
UP9620601072061980-01-4
STO-609
UP76551990452029-86-4
Dimethyl (2-oxo-3-(3-(trifluoromethyl)phenoxy)propyl)phosphonate
UP42098663654094-19-8
Imiquimod maleate
UP413659244896106-16-4
Racecadotril
UP44119095481110-73-8
N,N-Dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
UP448565124116817-11-9
2-Methoxyacetimidamide hydrochloride
UP9956343591903-91-9
Alizapride Hydrochloride
UP26235670459338-87-3
Tofogliflozin hydrate
UP8057707351201913-82-7
Dofequidar
UP285505797129716-58-1
Apatinib Mesylate
UP8490750641218779-75-9
Fmoc-Lys(Boc)-Wang resin 100-200 mesh, 1% DVB
UP8955540586N/A
Ceritinib
UP3100619761032900-25-6
Erdafitinib
UP5911669501346242-81-6
1-Benzylazetidin-3-yl methanesulfonate hydrochloride
UP715885859292163-60-1
Lithium 2-(quinolin-2-yl)acetate
UP701691539205655-39-6
(-)-Indolactam V
UP59484636390365-57-4
Evacetrapib
UP5037330831186486-62-3
ALK Inhibitor C29
UP2491169212093414-37-8
Valspodar
UP625059922121584-18-7
Rapastinel
UP276886306117928-94-6
Brefeldin A
UP22614793820350-15-6
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
UP76256304916321-99-6
Dopamine hydrochloride
UP43363681962-31-7
Esomeprazole Magnesium(Random Configuration)
UP321887994161973-10-0
Aluminum tris(trifluoromethanesulfonate)
UP55021560174974-61-1
Alectinib
UP2716504341256580-46-7
Pramipexole
UP870300951104632-26-0
GDC-0980
UP4224730511032754-93-0
Fmoc-Orn(Boc)-OH
UP968105540109425-55-0
Budipine
UP72322060557982-78-2
NMDA
UP8272692696384-92-5